Publications Clinical Pharmacology & Toxicology
2024
- Dahmke et al. Drugs - Real World Outcomes 2024 - Evaluation of Triple Whammy Prescriptions After the Implementation of a Drug Safety Algorithm
- Schönenberger et al. Res Social Adm Pharm. 2024 Feb 27 - Developing indicators for medication-related readmissions based on a Delphi consensus study
- Haschke et al. Br J Clin Pharmacol. 2024 - Food-derived compounds for CYP-phenotyping
- Gut et al. Swiss Med Wkly. 2024 - Use of metamizole and other non-opioid analgesics in Switzerland between 2014 and 2019: an observational study using a large health insurance claims database
- Anliker-Ort et al. J Clin Pharm. 2024 - Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study
- Möckli et al. BMC Health Serv Res. 2024 - How external and agency characteristics are related to coordination in homecare - findings of the national multicenter, cross-sectional SPOTnat study
- Christen et al. Nicotine & Tobacco Research, 2024 - Pharmacokinetics and pharmacodynamics of inhaled nicotine salt and free-base using an e-cigarette: A randomized crossover study
- Drewe et al. Pharmaceutics 2024 - Machine Learning-Based Analysis Reveals Triterpene Saponins and Their Aglycones in Cimicifuga racemosa
as Critical Mediators of AMPK Activation - Stuby et al. Thromb Res. 2024 - Oral anticoagulant therapy in older adults
- Goetschi et al. Eur J Pain. 2024 - Prescribing pattern insights from a longitudinal study of older adult inpatients with polypharmacy and chronic non-cancer pain
- Goetschi et al. Int J Clin Pharm 2024 - Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review
- Bekka et al. International Journal of Analytical Chemistry 2024 - Residents’ Knowledge regarding Recreational Drug Screening Immunoassays at a Swiss Hospital Group
- Bekka et al. Br J Clin Pharmacol. 2024 - Anticoagulation reversal (vitamin K, prothrombin complex concentrates, idarucizumab, andexanet-α, protamine)
- Waters et al. Clinical Toxicology 2024 - Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020
- Pahud de Mortanges et al. COVID 2024 - Effect of SARS-CoV-2 Infection on Renal and Hepatic Function after NSAID and Paracetamol Therapy
- Hermann et al. J Antimicrob Chemother 2024 - Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection
- Kamau et al. Int J Infect Dis. 2024 - Mosquitocidal efficacy and pharmacokinetics of single-dose ivermectin versus three-day dose regimen for malaria vector control in comparison with albendazole and no treatment: an open-label randomized controlled trial
Other publications
- Meyer-Massetti. Pflegerecht – Pflege in Politik, Wissenschaft und Ökonomie 2|2024 - Medikationsmanagement in Spitex-Organisationen – eine pharmazeutische Perspektive
2023
- Buetler et al. Clin Toxicol (Phila). 2023 - Characteristics of emergency department presentations following ingestion of Taxus baccata (yew)
- Dixe et al. Int. J. Environ. Res. Public Health 2023 - Patterns of Medication Management and Associated Medical and Clinical Features among Home-Dwelling Older Adults: A Cross-Sectional Study in Central Portugal
- Wernli et al. Int J Clin Pharm. 2023 - Pharmacists’ clinical roles and activities in inpatient hospice and palliative care: a scoping review
- Möckli et al. Heliyon. 2023 - Clarifying the muddy concept of home healthcare coordination: A comprehensive theoretical framework
- Mulder et al. Pharmacy 2023 - Counselling for Chronic Insomnia in Swiss Pharmacies: A Survey Study Based on Case Vignettes
- Möckli et al. International Journal of Nursing Studies 2023 - Care coordination in homecare and its relationship with quality of care: A national multicenter cross-sectional study
- Kern et al. Malaria Journal 2023 Jun 24 - Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes
- Favez et al. International Journal of Clinical Pharmacy - Exploring medication safety structures and processes in nursing homes: a cross‑sectional study
- Liakoni et al. Swiss Medical Forum | 2023;23(38) - Medikamentöse Unterstützung beim Rauchstopp
- Noseda et al. Journal of Clinical Medicine 2023 - Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study
- Schönenberger et al. BMC Health Serv Res. 2023 - Risk factors for medication-related short-term readmissions in adults - a scoping review
- Pereira et al. BMJ Open. 2023 - Development of a patient-centred medication management model for polymedicated home-dwelling older adults after hospital discharge: results of a mixed methods study
- Vallersnes et al. Int J Emerg Med 16, 86 (2023) - Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries
Case reports
Other publications
-
Lardi et al. pharmaJournal 5 | 5.2023. Inadäquate Polypharmazie erkennen – und «behandeln»
-
Banholzer et al. Swissmedic Vigilance-News | Edition 31 – November 2023. COVID-19-Impfstoffe: Wird die Einstufung «medizinisch wichtig» in den UAW-Meldungen korrekt angewendet, und gibt es Unterschiede zwischen den Meldungen von medizinischen Fachpersonen und von Patienten?
-
Bekka et al. pharma-kritik 2023; 45(3). Interaktionen von Phytopharmaka
2022
- Duthaler et al. Clin Pharmacokinet 2022 - Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel Phenotyping Cocktail Differently
- Varum et al. Int J Pharm. 2022 - Targeted colonic release formulations of mesalazine - A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis
- Schöning et al. J Transl Med. 2022 - Revalidating the prognostic COVID-19 severity assessment (COSA) score for variants of concern
- Heier et al. Eur J Emerg Med. 2022 - Clinical effect of ethanol co-use in patients with acute drug toxicity involving the use of central nervous system depressant recreational drugs
- Crulli et al. Clin Toxicol (Phila). 2022 - Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019
- Schöning et al. Pharmaceutics. 2022 - Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients
- Schöning et al. Front Pharmacol. 2022 - Effectiveness of Antiviral Therapy in Highly-Transmissable Variants of SARS-CoV-2: A Modeling and Simulation Study
- Wernli et al. J Pain Symptom Manage. 2022 - Subcutaneous Drugs and Off-label Use in Hospice and Palliative Care: A Scoping Review
- Schönenberger et al. Eur J Hosp Pharm. 2022 - Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing
- Wernli et al. Am J Hosp Palliat Care. 2022 - Prescription Trends in Hospice Care: A Longitudinal Retrospective and Descriptive Medication Analysis
- Pereira et al. BMJ Open. 2022 - Unplanned nursing home admission among discharged polymedicated older inpatients: a single-centre, registry-based study in Switzerland
- Gnägi et al. J Adv Nurs. 2022 - Development of a medication literacy assessment instrument (MELIA) for older people receiving home care
- Zerah et al. Age Ageing. 2022 - Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial
- Gerbier et al. Int J Environ Res Public Health. 2022 - Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study
- Schmid et al. Clin Toxicol (Phila). 2022 - Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex
Review articles
Case reports
- Stutz et al. Swiss Med Forum. 2022 - Rezidivierender Priapismus – unerwünschte Wirkung einer Therapie mit Neuroleptika
- Buetler et al. Front Med (Lausanne) 2022 - Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature
- Banholzer et al. Vigilance-News, Swissmedic, 2022 - Erfolgreiche Re-Exposition mit COVID-19-mRNA-Impfung in reduzierter Dosierung bei Patient mit klinischem Verdacht auf Peri-/Myokarditis nach erster COVID-19-Impfung
Other publications
- Schröder et al. pharmaJournal, 2022 - Das neue Vollstudium in Pharmazie an der Universität Bern
- Eschbach et al. pharmaJournal, 2022. - Pharmazeutisches Stationsmanagement – Aktueller Stand in Schweizer Spitälern und ein Ausblick in die Zukunft
- Meyer-Massetti et al. pharmaJournal, 2022 - Pharmazeutisches Stationsmanagement – Neue Aufgaben für die Pharma-Assistentinnen und –Assistenten
- Wernli et al. Sichere und rationale Medikation im Hospiz-Setting – eine neue Rolle für Apotheker:innen?
2021
- Preisig D et al. Eur J Pharm Biopharm. 2021 - Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: A clinical pharmacoscintigraphy study.
- Bachmann F et al. Clin Pharmacol Ther. 2021 - Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
- Drewe J et al. Molecules 2021 - Modelling structure activity relationship of AMPK activation.
- Wertli M et al. BMJ Open 2021 - Efficacy of metamizole versus ibuprofen and a short educational intervention versus standard care in acute and subacute low back pain: a study protocol of a randomised, multicentre, factorial trial (EMISI trial)
- Benowitz NL et Liakoni E. Addiction 2021 - Tobacco Use Disorder and Cardiovascular Health
- Kummer M et al. Int J Environ Res Public Health 2021 - Characteristics of Presentations to the Emergency Department Following Attempt Suicide with Drugs
- Blaser LS et al. Front Pharmacol 2021 - Comparative Effects of Metamizole (Dipyrone) and Naproxen on Renal Function and Prostacyclin Synthesis in Salt-Depleted Healthy Subjects - A Randomized Controlled Parallel Group Study
- Benowitz NL et al. J Clin Pharmacol 2021 - Clincal Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame
- Miro O et al. Clin Toxicol 2021 - Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departements
- Müller AM, et al. J Gen Intern Med 2021 - The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study
- Liakoni E, et al. Pharmacogenet Genomics 2021 - Effect of race and glucuronidation rates on the relationship between nicotine metabolite ration and nicotine clearance
- Kern C, et al. Front Pharmacol 2021 - Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
- Duthaler U, et al. Plos Pathogens 2021 - The pharmacokinetics and drug-drug interactions of ivermectin in Aedes aegypti mosquitoes
- Nicolas P, et al. Parasites Vectors 2021 - Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study
- Vischer AS, et al. Cells 2021 - Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
- Banholzer S, et al. SMW 2021 - Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission
- Schöning V, et al. J Transl Med 19, 56 (2021) - Development and validation of a prognostic COVID-19 severity assessment (COSA) score and machine learning models for patient triage at a tertiary hospital.
- Zerah L, et al. BMC Geriatr 2021 - Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial
- Zerah L, et al. Age Ageing. 2021 - Performance of a trigger tool for detecting drug-related hospital admissions in older people: analysis from the OPERAM trial
- Glinz D, et al. J Hypertens. 2021 - Hemodynamic profiles in treatment-naive arterial hypertension and their clinical implication for treatment choice: an exploratory post hoc analysis
- Chaccour C, et al. EClinicalMedicine. 2021 - The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
- Helma C, et al. Front Pharmacol. 2021 - A Comparison of Nine Machine Learning Mutagenicity Models and Their Application for Predicting Pyrrolizidine Alkaloids
- Diedrich D, et al. Z Gerontol Geriatr. 2021 - Medikationsmanagement in der häuslichen Pflege – der Medikationsprozess aus der Perspektive von Klient:innen und ihren Angehörigen
- Romann V, et al. Swiss Med Wkly. 2021 - Presentations with reported methamphetamine use to an urban emergency department in Switzerland
2020
- Chaccour, et. al. Sci Rep 2020 - Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats
- Grafinger, et. al. Br J Clin Pharmacol 2020 - Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
- Schmid, et. al. Drug Alcohol Depend 2020 - Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland
- St Helen, et. al. Cancer Prev Res (Phila) 2020 - Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention
- Liakoni, et. al. Nicotine Tob Res 2020 - Effects of Nicotine Metabolic Rate on Cigarette Reinforcement
- Suenderhauf, et. al. Br J Clin Pharmacol 2020 - Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults
- Boschung-Pasquier, et. al. Clin Microbiol Infect 2020 - Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study
- Bachmann, et al. Clin Pharmacol Ther 2020 - Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2
- Stojkov, et al. Blood Adv 2020 - Guideline-based indicators for adult patients with myelodysplastic syndromes
- Scholz, et al. Br J Pharmacol 2020 - Effects of Hypericum perforatum (St John's wort) on the pharmacokinetics and pharmacodynamics of rivaroxaban in humans
- Cismaru, et al. Genes 2020 - Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
- Cismaru, et al. Front Gen 2020 - High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis
- Noseda, et al. Clin Toxicol 2020 - MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017
- Chaccour, et al. Am J Trop Med Hyg 2020 - Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
- Bachmann et al., Bioanalysis 2020 - Development and validation of an LC-MS/MS method for the bioanalysis of the major metamizole metabolites in human plasma
- Liakoni, et al. Swiss Medical Weekly 2019 - Characteristics of emergency department presentations requiring consultation of the national Poisons Information Centre
- Piotrowska, et al. Emerg Med Intern 2019 - Presentations Related to Acute Paracetamol Intoxication in an Urban Emergency Department in Switzerland
- Duthaler, et al. J Antimicrob Chemother 2019 - The effect of food on the pharmacokinetics of oral ivermectin
2019
- Schmid, et al. Drug Alc Dep 2019 - Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland
- Liakoni, et al. Nicotine and Tobacco Research 2019 - Effects of Nicotine Metabolic Rate on Cigarette Reinforcement
- Ziesenitz, et al. Eur J Clin Pharm 2019 - Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study
- Rudin, et al. Eur J Intern Med 2019 - Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients
- Benowitz, et al. Drug Alcohol Depend 2019 - Quantitative biochemical screening for marijuana use and concordance with tobacco use in urban adolescents
- Grafinger, et al. Br J Clin Pharm 2019 - Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
- Liakoni, et al. Drug Alcohol Depend 2019 - Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers
- St Helen, et al. Cancer Prev Res 2019 - Comparison of Systemic Exposure to Toxic and/or Carcinogenic Volatile Organic Compounds (VOC) during Vaping, Smoking, and Abstention
- Boschung-Pasquier, et al. Clin Micro-biol Infect 2019 - Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study
- Scholz, et al. SMW 2019 - Emergency department presentations related to abuse of prescription and over-the-counter drugs in Switzerland: time trends, sex and age distributions
- Hoemme, et al. Cancer Chemother Pharmacol 2019 - Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer
- Rudin, et al. Biochem Pharmacol 2019 - Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells